Publication Name	World Journal of Experimental Medicine
Manuscript ID	99235
Country	India

Received	2024-07-17 14:05
Peer-Review Started	2024-07-17 14:06
To Make the First Decision
Return for Revision	2024-08-15 10:45
Revised	2024-09-08 12:34
Second Decision	2024-09-20 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-20 07:37
Articles in Press	2024-09-20 07:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-23 10:56
Publish the Manuscript Online	2024-10-31 07:40

ISSN	2220-315x (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Minireviews
Article Title	Intravitreal therapy for the management of diabetic retinopathy: A concise review
Manuscript Source	Invited Manuscript
All Author List	Atul Arora, Arvind K Morya, Parul C Gupta, Nitin K Menia, Prateek Nishant and Vishali Gupta
Funding Agency and Grant Number
Corresponding Author	Arvind K Morya, Doctor, MNAMS, MS, Academic Editor, Doctor, Doctor, Professor, Researcher, Science Editor, Senior Lecturer, Senior Researcher, Surgeon, Head of the Department, Department of Ophthalmology, All India Institute of Medical Sciences, Bibi Nagar, Hyderabad 508126, Telangana, India. bulbul.morya@gmail.com
Key Words	Diabetic retinopathy; Intravitreal therapy; Anti-vascular endothelial growth factor; Macular edema; Proliferative diabetic-retinopathy
Core Tip	Intravitreal therapy has revolutionized the treatment for diabetic retinopathy (DR). The various treatment options include intravitreal anti-vascular endothelial growth factor injections, triamcinolone acetonide and steroid implants. Intravitreal therapy can be used for the management of Diabetic Macular Edema and Proliferative Diabetic Retinopathy. Additionally, corticosteroids have shown promising results by exerting anti-inflammatory effects and stabilizing blood-retinal barrier integrity. Recent advancements have introduced novel agents targeting various pathways implicated in DR pathogenesis, such as angiopoietin-2 and integrins, offering potential avenues for tailored therapeutic interventions. This review aims to comprehensively examine diverse facets of intravitreal therapy concerning the management of DR and its associated complications.
Publish Date	2024-10-31 07:40
Citation	<p>Arora A, Morya AK, Gupta PC, Menia NK, Nishant P, Gupta V. Intravitreal therapy for the management of diabetic retinopathy: A concise review. <i>World J Exp Med</i> 2024; 14(4): 99235</p>
URL	https://www.wjgnet.com/2220-315x/full/v14/i4/99235.htm
DOI	https://dx.doi.org/10.5493/wjem.v14.i4.99235

Full Article (PDF)	WJEM-14-99235-with-cover.pdf
Manuscript File	99235_Auto_Edited_015445.docx
Answering Reviewers	99235-answering-reviewers.pdf
Audio Core Tip	99235-audio.mp3
Conflict-of-Interest Disclosure Form	99235-conflict-of-interest-statement.pdf
Copyright License Agreement	99235-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	99235-non-native-speakers.pdf
Peer-review Report	99235-peer-reviews.pdf
Scientific Misconduct Check	99235-scientific-misconduct-check.png
Scientific Editor Work List	99235-scientific-editor-work-list.pdf
CrossCheck Report	99235-crosscheck-report.pdf
CrossCheck Report	99235-crosscheck-report.png